ANN ARBOR - Aquaro Histology announced Thursday it has completed a $9.8 million Series A round led by Telegraph Hills Partners. Aquaro, formerly known as Aquaro Biosystems, will use the money to launch its first product, an Automated Section Mounting used in medical research and development. Concurrent with the financing, Tom Raffin, M.D.; Deval Lashkari,
ANN ARBOR - Genomenon has announced that it will begin offering a free edition of the Mastermind Genomic Search Engine to clinical, research and academic institutions to advance genomic analysis and DNA data interpretation. Genomenon is making Mastermind freely available to promote more rapid advances in genome analysis and DNA sequencing interpretation. Mastermind is a
ANN ARBOR - An injury pathway in the neurons of fruit flies may cause the loss of synapses in diseases such as Alzheimer's and ALS, according to University of Michigan researchers. This pathway, called DLK, has received recent attention as a candidate drug target because it contributes to the deterioration of damaged neurons. The new
GRAND RAPIDS - The monthly Health Forum of West Michigan series begins its new year with a panel discussion that focuses on the supply and demand of health care jobs, and how area higher education institutions are working to meet the needs of industry employers and employees. "The Health Care Talent Pipeline" is set for
ANN ARBOR - The University of Michigan is partnering on an ambitious $20 million project to grow new heart tissue for cardiac patients. The new research center has been awarded to Boston University, with strong partnership from U-M and Florida International University. "A heart attack creates scar tissue, and the heart never returns to full
LANSING — Neogen Corp. will spend $1.3 million on a new home for its Ideal Instruments subsidiary that makes veterinary drug delivery instruments. Neogen develops and markets food and animal safety products The project includes a complete rehabilitation of the building, which has been deemed functionally obsolete by the city of Lansing. The $1.3 million
ANN ARBOR — The cholesterol-fighting drug developer Esperion Therapeutics Tuesday announced an initial public offering of $150 million of its common stock. Esperion also expects to grant the underwriters a 30-day option to purchase up to $22.5 million of additional shares of its common stock. The company said it would use the net proceeds of
ANN ARBOR - The University of Michigan has received a $58 million five-year grant to help researchers turn their best ideas and discoveries into tests, treatments, care innovations and cures through training, funding and central research services. The grant is from the National Institutes of Health's National Center for Advancing Translational Sciences through its Clinical
ANN ARBOR - With yogurt and crushed glass, University of Michigan researchers have taken a step toward using visible light to image inside the body. Their method for focusing light through these materials is much faster and simpler than today's dominant approach. Dense structures like bone show up clearly in x-rays, but softer tissues like
ANN ARBOR - Advanced life science technology companies from Southeast Michigan will provide an eight-minute pitch June 7 outlining their products, their technology and their market opportunity. They will also detail recent accomplishments such as FDA submissions, technical accomplishments, and manufacturing milestones. After each company has presented, we will have a question and answer session.
